Michael Colin
Rheumatology · New York, NYNPI 1366504482
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,029 of the $9,330 with a category attached, or 86.1%. It is spread thinly across 29 manufacturers, the largest accounting for just 23.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $4,883 and has fallen 97.1% since, to $142 in 2024.
Across 298 payments — averaging $31.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$2K
- Biohaven Pharmaceuticals, Inc.$1K
- Lilly USA, LLC$1K
- Novartis$772
- Pfizer$551
- Regeneron Healthcare Solutions, Inc.$444
- plus $3K from 23 others
What the payments were for
- Consulting fees$1,20013%
- Food & beverage$8,02986%
- Education$1011%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 61 | $2,216 |
| Biohaven Pharmaceuticals, Inc. | 2 | $1,216 |
| Lilly USA, LLC | 40 | $1,055 |
| Novartis | 34 | $772 |
| Pfizer | 32 | $551 |
| Regeneron Healthcare Solutions, Inc. | 13 | $444 |
| Mallinckrodt Enterprises LLC | 18 | $413 |
| Biohaven Pharmaceutical Holding Company Ltd. | 8 | $382 |
| Johnson & Johnson | 15 | $347 |
| UCB, Inc. | 17 | $337 |
| AbbVie(2 entities) | 11 | $288 |
| Mallinckrodt Hospital Products Inc. | 8 | $264 |
| GSK | 6 | $145 |
| Sanofi | 2 | $140 |
| Antares Pharma, Inc. | 7 | $131 |
| Radius Health, Inc. | 1 | $121 |
| Regeneron | 1 | $119 |
| E.r. Squibb & Sons, L.L.C. | 4 | $57 |
| Genentech USA, Inc. | 3 | $53 |
| AstraZeneca(2 entities) | 3 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Hikma Pharmaceuticals USA | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| Octapharma USA, Inc. | 1 | $30 |
| Kowa Pharmaceuticals America, Inc. | 1 | $24 |
| Ironwood Pharmaceuticals, Inc | 1 | $21 |
| Merck | 1 | $19 |
| Novo Nordisk | 1 | $17 |
| Medexus Pharma, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,330 in reported general payments places this provider in the 70th percentile of 541 rheumatology providers in New York.
Other rheumatology in New York
- Laurie GlimcherNew York$3.9M
- Grace WrightNew York$3M
- Sergio SchwartzmanNew York$2.5M
- Allan GibofskyNew York$1.9M
- Petros EfthimiouNew York$791K
- Olga PetrynaNew York$509K
- Danielle PeterselNew York$461K
- Jose ScherNew York$446K
- Jason FallerNew York$357K
- Lindsay LallyNew York$340K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.